遗传性与神经肌肉病相关扩张型心肌病风险分层的影像学作用
本文综述遗传性和神经肌肉病相关扩张型心肌病(DCM)的影像学风险分层作用。超过50个致病基因已被描述,肌节蛋白和核纤层蛋白A/C突变最常见;突变携带者常无症状直至出现心衰、心律失常或心源性猝死。先进影像技术(组织多普勒、斑点追踪应变、心血管磁共振、核素成像)可早期检测细微结构和功能异常,并在明确DCM后对左室射血分数提供增量风险分层价值。
要点
- 遗传性DCM突变携带者常无症状,早期识别需先进影像技术检测细微异常。
- 组织多普勒和斑点追踪应变可早期发现功能异常,CMR提供组织定性和心肌能量学信息。
- 明确DCM后,超声心肌力学和CMR组织定性对LVEF有增量风险分层价值。
核心结论
- 先进影像技术有助于遗传性DCM突变携带者的早期诊断,并在明确DCM后提供超越LVEF的风险分层信息。
研究设计与样本
- 本文为综述,总结影像学在遗传性DCM尤其神经肌肉病相关DCM风险分层中的作用。
主要发现
- 超过50个致病基因已被描述,肌节蛋白和核纤层蛋白A/C突变最常见。
- 突变携带者常无症状直至心衰、心律失常或心源性猝死表现。
- 组织多普勒和斑点追踪应变可早期检测功能异常。
- 心血管磁共振提供组织定性和心肌能量学信息,核素成像提供细胞功能信息。
- 明确DCM后,超声心肌力学和CMR组织定性对LVEF有增量风险分层价值。
临床怎么用
- 对遗传性DCM突变携带者可采用先进超声和CMR技术早期检测细微异常。
- 明确DCM后结合超声心肌力学和CMR组织定性进行风险分层。
局限性
- 需进一步研究影像技术如何帮助早期选择延缓疾病进展的管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The etiology of dilated cardiomyopathy (DCM) can be grouped as either genetic or nongenetic. More than 50 pathogenic genes have been described, with sarcomeric and lamin A/C mutations being the most common. Mutation carriers for genetic DCM are often asymptomatic until cardiac disease manifests with heart failure, arrhythmias, or sudden cardiac death. Preventive strategies are promising but can only be applied and tested adequately if genetic DCM can be diagnosed at an early stage. Early diagnosis of mutation carriers that may develop overt DCM requires advanced imaging techniques that can detect subtle structural and functional abnormalities. Advanced echocardiographic techniques such as tissue Doppler imaging and speckle tracking strain analysis permit early detection of functional abnormalities, whereas cardiovascular magnetic resonance techniques provide information on tissue characterization and myocardial energetics that may be altered at an early stage. Furthermore, nuclear imaging techniques provide information on cellular function (metabolism, perfusion). Once the diagnosis of overt DCM has been established, various imaging parameters such as echocardiography-based myocardial mechanics and cardiovascular magnetic resonance-based tissue characterization have shown incremental benefit to left ventricular ejection fraction in risk stratification. Further research is required to understand how imaging techniques may help to choose management strategies that could delay progression when instituted early in the course of the disease. The present article reviews the role of imaging in the risk stratification of genetic DCM in general, with specific emphasis on DCM associated with neuromuscular disorders.
引用
- van der Bijl P, Delgado V, Bootsma M, et al. Risk Stratification of Genetic, Dilated Cardiomyopathies Associated With Neuromuscular Disorders: Role of Cardiac Imaging. Circulation. 2018. PMID: 29866775. doi:10.1161/CIRCULATIONAHA.117.031110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。